Table 1.
Baseline characteristics and outcome (n=17)
| Age | 63.12±10.39 |
| Male sex | 16 (94.1) |
| Body mass index (BMI) | 29.12±4.85 |
| Comorbidities | |
| Diabetes | 5 (29.4) |
| Chronic lung disease | 4 (23.5) |
| Cardiovascular disease | 5 (29.4) |
| Active malignancy | 1 (5.9) |
| No significant comorbidities | 6 (35.3) |
| Biochemistry and blood counts | |
| C-reactive protein (mg/mL) | 217.00 (167.00, 334.00) |
| Haemoglobin (mmol/L) | 7.60 (5.10, 8.80) |
| Platelets (109/L) | 270.00 (215.00, 326.00) |
| Leucocytes (109/L) | 9.70 (5.10, 18.50) |
| Neutrophils (109/L) | 7.23 (6.15, 10.25) |
| Lymphocytes (109/L) | 0.88 (0.74, 1.40) |
| Monocytes (109/L) | 0.56 (0.36, 0.75) |
| Disease severity | |
| SOFA | 9.00 (7.00, 10.00) |
| Outcome measures | |
| Days in ICU | 31.00 (19.50, 40.50) |
| ICU mortality | 4 (23.5) |
| 90-day mortality | 5 (29.4) |
Results are reported as n (%), mean±SD or median (range).
ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment.